retatrutide unauthorized sales This week's headlines highlight the growing global threat posed by counterfeit and unregulated medicines. As experimental use increases, clinicians are warning about the uncertainty of what's actually in products claiming to Some Providers Prescribe Unapproved Retatrutide

Weight loss of 2-4 pounds per week is common

An improved version of ProSavin , OXB-102 (NCT03720418, Table 1), is under investigation in a two-phase trial including an open-label, dose-finding phase, in which patients will receive one of three escalating doses, and a randomized, double-blind phase in which patients will be randomized to either an active group receiving the selected dose from phase 1, or a control group

When patients are fully informed about the trade-offs, they are more likely to commit to consistent therapy

Why genetics matter before you titrate the GIPR variable GLP-1 response varies meaningfully across patients, and the variation is partially genetic

Moreover, Ma et al